Skip to main content
Nevada Public Radio
  • News 88.9 KNPR
  • Classical 89.7 kcnv
  • Magazine Desert Companion
  • About

    How to reach us

    1289 S. Torrey Pines Dr.
    Las Vegas, NV 89146

    Main Number:  1-702-258-9895
    Toll Free: 1-888-258-9895

    More contact info

     

     

      • Staff
      • Board of Directors
      • Employment
      • FCC Applications
      • CPB Compliance
      • Our Policies
      • Listen on the Radio
      • Other Ways to Listen
      • Sign-up for NVPR News
      • FCC Public Inspection File
      • CPB Funding
      • History
    • News 88.9 KNPR
    • Classical 89.7 KCNV
    • Desert Companion
  • Programs
  • Events
  • Support
  • myPublicRadio
  • Donate Now

Main menu

Search

Listen

News 88.9 KNPR
Classical 89.7 KCNV
Podcasts view all

member station

Support

Subscribe to Sackler Family

Sackler Family

NPR
National
Family members exchange photographs of their lost loved ones in the lobby of the Akin Gump law firm offices on Thursday in Manhattan, NY. The family members and victims gave statements to the U.S. Bankruptcy Court with the Sackler family, who own Purdue

For the first time, victims of the opioid crisis formally confront the Sackler family

Mar 10, 2022
The Sacklers, who own Purdue Pharma, maker of Oxycontin, have maintained they did nothing wrong. People who lost loved ones and years of their lives to opioid addiction believe otherwise.
  • Listen Download
NPR
Business

Sackler family is willing to pay more in Purdue opioids settlement, mediator says

Feb 18, 2022
Under the latest proposal, the Sacklers would contribute between $5.5 billion and $6 billion, an increase from the $4.3 billion they had agreed to earlier.
NPR
National
Demonstrators scattered fake money and prescription bottles of OxyContin outside of The United States Bankruptcy Court in response to the overdose crisis.

The Purdue Pharma Deal Would Deliver Billions, But Individual Payouts Will Be Small

Sep 28, 2021
People who were addicted to OxyContin or lost loved ones who were addicted to the drug expect very little in compensation from the multibillion-dollar Purdue Pharma bankruptcy settlement.
NPR
National
Purdue Pharma filed for bankruptcy with a more than $10 billion plan to settle claims that it fueled the U.S. opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller. The company's headquarters in Stamford, Conn., is shown here i

The Justice Department Moves To Block The Purdue Pharma Sackler Bankruptcy Deal

Sep 16, 2021
The DOJ is seeking to block implementation of any part of the Purdue Pharma bankruptcy deal until legal challenges are settled. The deal granted Sackler family members immunity from opioid lawsuits.
NPR
National
Two demonstrators protest against U.S. Judge Robert Drain, who has granted immunity from future opioid lawsuits to members of the Sackler family.

The Sacklers, Who Made Billions From OxyContin, Win Immunity From Opioid Lawsuits

Sep 01, 2021
The decision by a federal bankruptcy judge grants members of the family who own Purdue Pharma, maker of OxyContin, sweeping protection from any liability for the opioid crisis.
  • Listen Download
NPR
National
David and Kathe Sackler, members of the family that owns Purdue Pharma, the maker of OxyContin, testified via video to a House Oversight Committee hearing on Dec. 17, 2020. Sackler family members have acknowledged that the drug had a role in the opioid c

The Sacklers Want Immunity From The Opioid Crisis For A Long List Of Their Associates

Aug 20, 2021
In the Purdue Pharma bankruptcy trial now underway, scrutiny has focused on the Sacklers' demand for immunity from opioid lawsuits that would extend to a vast network of individuals and businesses.
  • Listen Download
NPR
National
Signage for Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Connecticut. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, are facing hundreds of lawsuits across the country for the company's al

As Purdue Pharma Bankruptcy Nears Approval, Family Members Write About The Human Toll

Aug 09, 2021
The Purdue Pharma bankruptcy process has focused on financial compensation to creditors, but court records include heartrending personal letters from families ravaged by Oxycontin.
  • Listen Download
NPR
Health
A 2013 file photo shows OxyContin pills at a pharmacy in Montpelier, Vt.

Justice Department Blasts Purdue Pharma's Bankruptcy Plan

Jul 19, 2021
Two divisions of the DOJ argue the deal improperly shelters members of the Sackler family and their associates from liability. States are finalizing a separate deal with other opioid companies.
NPR
Health
Purdue Pharma faced an avalanche of lawsuits for alleged harm caused by its prescription opioid medicine OxyContin. A controversial bankruptcy deal expected to be finalized next month would block lawsuits against members of the Sackler family who own the

15 States Drop Opposition To Controversial Purdue Pharma Oxycontin Bankruptcy

Jul 07, 2021
Massachusetts and New York are among the states agreeing to end the fight to halt a controversial Purdue Pharma bankruptcy plan. The deal shelters members of the Sackler family from opioid lawsuits.
NPR
National
Members of the Sackler family who own Purdue Pharma, the maker of Oxycontin, moved a step closer to winning immunity from opioid lawsuits.

Sackler Family Empire Poised To Win Immunity From Opioid Lawsuits

Jun 02, 2021
A federal bankruptcy judge cleared a plan for final vote by Purdue Pharma's creditors that would release members of the Sackler family and their financial empire from liability for the opioid crisis.
  • Listen Download
NPR
National
David (left) and Kathe Sackler, members of the family that owns Purdue Pharma, the maker of Oxycontin, testified via video to a House Oversight Committee hearing on Dec. 17, 2020. Sackler family members have acknowledged that the drug had a role in the o

24 States Mount Legal Fight To Block Sackler Bid For Opioid Immunity

May 03, 2021
Under a bankruptcy procedure prohibited by courts in part of the country, the Sacklers could be sheltered from opioid lawsuits even without declaring bankruptcy. Some states are crying foul.
  • Listen Download
NPR
National
A federal judge extended a block on lawsuits against members of the Sackler family, owners of Purdue Pharma, until April 21. The drug-maker filed for bankruptcy in 2019, facing an avalanche of claims linked to the marketing and sale of its highly addicti

Judge Blocks Lawsuits Against Sackler Family As Oxycontin Bankruptcy Talks Continue

Mar 24, 2021
Two dozen states had hoped to sue the owners of Purdue Pharma for their alleged role in the opioid crisis. But a federal bankruptcy has judge put the brakes on — again — until April 21.
NPR
National
Purdue Pharma, maker of the highly addictive OxyContin, is keeping secret the results of an investigation of the Sacklers. Critics want the findings made public.

Purdue Pharma Conducted Massive Probe Of The Sacklers, But The Findings Are Secret

Mar 19, 2021
Attorneys, forensic analysts and other financial experts working for Purdue Pharma spent nearly two years looking for evidence of wrongdoing by the Sacklers. Critics want the findings made public.
  • Listen Download
NPR
National
OxyContin pills arranged at a pharmacy in Montpelier, Vt. Purdue Pharma makes the highly addictive drug.

Purdue Pharma Offers Restructuring Plan, Sackler Family Would Give Up Ownership

Mar 15, 2021
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.
  • Listen Download
NPR
National
Tufts employee Gabe Ryan removes letters from signage featuring the Sackler family name at the Tufts building in Boston on Dec. 5, 2019. Tufts University was the first major university to strip the Sackler name from buildings and programs.

Sacklers Face House Panel Over Purdue Pharma Oxycontin Sales

Dec 17, 2020
Members of the family have worked to keep their role in Purdue Pharma's operations private. In a surprise move, David and Kathe Sackler agreed to testify under oath.
NPR
National

McKinsey Apologizes For Helping Purdue Pharma 'Turbocharge' Opioid Sales

Dec 09, 2020
The corporate consulting giant issued a rare apology for its behind-the-scenes work with Purdue Pharma, maker of OxyContin. One senator called McKinsey's behavior "abhorrent."
NPR
National
Newly public documents detail the role of members of the Sackler family, owners of OxyContin maker Purdue Pharma, during years when the privately owned drug company launched criminal schemes designed to "turbocharge" sales of Oxycontin and other highly a

Critics Want Sacklers To Face Criminal Charges For Role In Opioid Crisis

Nov 25, 2020
A new plea deal with the Justice Department is the second time the family-owned company admitted criminal schemes to boost Oxycontin sales. Despite their hands-on role, the Sacklers face no charges.
  • Listen Download
NPR
Law

Federal Judge Approves Landmark $8.3 Billion Purdue Pharma Opioid Settlement

Nov 17, 2020
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.
NPR
National
Purdue Pharma headquarters in Stamford, Conn., in 2019. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have faced hundreds of lawsuits over the company's alleged role in the opioid epidemic that has killed more than 200,000 Am

Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales

Oct 21, 2020
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.
  • Listen Download
NPR
Law
Tufts University stripped the Sackler name from several of its buildings and divisions earlier this month, citing the billionaire family's role in the opioid crisis. The founders of Purdue Pharma have come under intense scrutiny for how their company mis

Sacklers Withdrew Nearly $11 Billion From Purdue As Opioid Crisis Mounted

Dec 17, 2019
According to a court filing Monday, the family pulled about $10.7 billion from Purdue since 2008 — ramping up withdrawals even after executives pleaded guilty to misleading regulators about OxyContin.
NPR
National
Family and friends who lost loved ones to OxyContin and opioid overdoses left pill bottles in protest outside the Stamford, Conn., headquarters of Purdue Pharma in August 2018.

Partisan Divide Grows Over Opioid Settlement Plan

Oct 20, 2019
While most Republican attorneys general embrace Purdue Pharma's structured bankruptcy plan, all but two Democratic attorneys general reject it. "This is a moral issue for them," one expert says.
  • Listen Download
NPR
National
Purdue Pharma headquarters in Stamford, Conn, shown last week. The company, which makes OxyContin and other drugs, filed court papers in New York on Sunday seeking Chapter 11 bankruptcy protection.

Purdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11

Sep 15, 2019
The bankruptcy follows the Sackler family, which owns Purdue, agreeing to surrender control of the company and offering $3 billion in cash to opioid-hit communities.
NPR
Law
Members of P.A.I.N. (Prescription Addiction Intervention Now) and Truth Pharm staged a protest on Thursday outside Purdue Pharma headquarters in Stamford, Conn., over its recent controversial opioid settlement.

New York AG Says Sacklers Transferred $1B From Pharma Accounts To Themselves

Sep 13, 2019
The revelation comes after almost two dozen states reached a tentative settlement with the maker of OxyContin.
  • home
  • How to reach us
  • About
  • Support
  • Twitter
  • Facebook
  • NVPR News
  • Instagram

© All Rights Reserved. | Privacy Policy

PRXNPRAPMBBC INN